Skip to content

Digene OTC (over the counter) patient profiling, to determine patient acceptability and satosfaction of the product: A Pharmacy Based Observational Study

Digene OTC (over the counter) patient profiling, with patient acceptability and satisfaction: A Pharmacy based research

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2012/08/002912
Enrollment
1500
Registered
2012-08-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Dyspepsia

Interventions

None listed

Sponsors

Abbott India Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male and female patients aged between 18 and 65 years (both inclusive) who visit the pharmacy to purchase Digene without prescription. 2. Must be able and willing to voluntarily sign and date the patient authorization. Should be willing to provide feedback through telephone. 3. Ability to read and understand English or local language.

Exclusion criteria

Exclusion criteria: 1. Patient who is not willing to provide information or contact details. 2. If the person purchasing the drug is not the patient himself/herself. 3. Patient unable to read and understand English or the local language are excluded from the study. 4. Female patients who are pregnant or lactating will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
â?¢ Patient profile of Digene will provide information about demographic variables, symptom presentation and previous history of Digene use etc.Timepoint: Enrollment period

Secondary

MeasureTime frame
â?¢ To assess the patient acceptability and satisfaction with Digene among the OTC users â?¢ To assess the symptom relief with Digene in OTC usersTimepoint: Follow up visit

Countries

India

Contacts

Public ContactDr Rajendran Krishnan Nair
trc.trivandrum@gmail.com04714010253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026